5
项与 Anti-CD30 CAR-T (Shanghai SongGe ) 相关的临床试验An Exploratory Clinical Study of the Safety and Efficacy of Chimeric Antigen Receptor T-Cells (CAR T-Cells) in Subjects with Relapsed/Refractory Hematologic Malignancy
This study is a single-center, open-label clinical trial of single-dose of CAR T-cells in subjects with relapsed/refractory hematologic malignancy.
An exploratory clinical study to evaluate the safety and efficacy of anti CD30 CAR T cell injection (anti CD30 CAR T cells) in patients with CD30+relapsed/refractory lymphoma
/ Unknown status早期临床1期IIT An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells Injection (Anti CD30 CAR T Cells) in Patients With CD30+ Relapsed/Refractory Lymphoma
This is a single-center, open label, single dose study of anti CD30 CAR-T cells injection in treatment of patients with relapsed/refractory CD30+ lymphoma.
100 项与 Anti-CD30 CAR-T (Shanghai SongGe ) 相关的临床结果
100 项与 Anti-CD30 CAR-T (Shanghai SongGe ) 相关的转化医学
100 项与 Anti-CD30 CAR-T (Shanghai SongGe ) 相关的专利(医药)
100 项与 Anti-CD30 CAR-T (Shanghai SongGe ) 相关的药物交易